Oncology Meeting Resources

In this section, you can find all available abstracts, presentations and webcasts on OncologyPRO.

Here below, you can search across all meeting resources by session title, presentation title, presenter or keyword. Results can then be refined by topic, event and publication date.

The use of these presentations is for personal educational purposes only.
ESMO thanks the authors for their generosity.




Format available

http://oncologypro.esmo.org/Meeting-Resourc...f-resistance-and-biomarkers-in-immunotherapy

Date: 19 Nov 2017
Presenter: Christian Blank
Resources: Presentation, Webcast
Topics: Biomarkers, Cancer Immunology and Immunotherapy, Melanoma and other Skin Tumours, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...oma.-Is-it-different-from-cutaneous-melanoma

Date: 19 Nov 2017
Presenter: Richard Scolyer
Resources: Presentation, Webcast
Topics: Melanoma and other Skin Tumours, Pathology/Molecular Biology, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...ffered-paper-session-4-Invited-Discussant-1O

Date: 19 Nov 2017
Presenter: Patrick Tan
Resources: Presentation, Webcast
Topic: Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...y-treated-patients-from-the-MAGIC-trial-193O

BackgroundTranscriptomics has defined novel molecular subgroups of gastroesophageal cancer (GC), however the prognostic value of these classifications has not been evaluated in the context of standard treatment.

Date: 19 Nov 2017
Presenter: Elizabeth Smyth
Resources: Abstract, Presentation, Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Gastric Cancer, Gastrointestinal Cancers, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...ered-paper-session-4-Invited-Discussant-193O

Date: 19 Nov 2017
Presenter: Florian Lordick
Resources: Presentation, Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Gastric Cancer, Gastrointestinal Cancers, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...a-2017-Congress/Immune-checkpoint-inhibitors

Date: 19 Nov 2017
Presenter: Radha Raghupathy
Topics: Lymphomas, Cancer Immunology and Immunotherapy, Haematologic Malignancies, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...ress/Signalling-pathways-and-targeted-agents

Date: 19 Nov 2017
Presenter: Peter Johnson
Resources: Presentation, Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Lymphomas, Haematologic Malignancies, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...se-finding-portion-of-a-phase-1-2-study-419O

BackgroundThe rearranged during transfection (RET) fusion gene was discovered as a driver oncogene in 1–2% of non-small cell lung cancer (NSCLC). Alectinib (300 mg BID) has been approved for the...

Date: 19 Nov 2017
Presenter: Kaname Nosaki
Resources: Abstract, Presentation, Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Biomarkers, Non-Small-Cell Lung Cancer, Metastatic, Lung and other Thoracic Tumours, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...h-resected-lung-adenosquamous-carcinoma-396O

BackgroundProgrammed cell death ligand 1 (PD-L1) expression by immunohistochemistry (IHC) is a predictive factor for anti–PD-1/PD-L1 monoantibodies. However, intertumoral heterogeneity of PD-L1...

Date: 19 Nov 2017
Presenter: Yiwei Liu
Resources: Abstract
Topics: Biomarkers, Cancer Immunology and Immunotherapy, Lung and other Thoracic Tumours, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...-Oncogenic-Fusions-in-Diverse-Tumor-Types-1O

BackgroundKinase fusions (KFN) are well recognized as targetable drivers in some cancers, and KFN common in one disease can be found in unrelated histologies, as for BRAF.

Date: 19 Nov 2017
Presenter: Sadakatsu Ikeda
Resources: Abstract, Presentation, Webcast
Topic: Translational Research